新型抗高血压药物研究进展  

Research progress on new antihypertensive drugs

作　　者：魏婷[1] 张宁汝[1] Wei Ting;Zhang Ningru(The first affiliated hospital of Bengbu Medical College,Bengbu,Anhui,233000,China)

机构地区：[1]蚌埠医学院第一附属医院,安徽蚌埠233000

出　　处：《齐齐哈尔医学院学报》2022年第10期968-973,共6页Journal of Qiqihar Medical University

基　　金：安徽省自然科学青年项目基金(1908085QH353);蚌埠医学院优秀人才基金(by51201315);安徽省教育厅高校协同创新项目基金(GXXT-2020-019)。

摘　　要：高血压是以动脉压升高为主要临床表现的心血管综合征,可损伤重要脏器,导致中风、冠状动脉疾病、心力衰竭和慢性肾衰竭等靶器官的损害。但在现有的治疗方法中,高血压在世界范围内控制效果仍然不佳,因此新型抗高血压的治疗靶点与药物的研发依旧是治疗高血压过程中的重中之重。Hypertension is a cardiovascular syndrome with elevated arterial pressure as the main clinical manifestation,which can damage important organs and lead to the damage of target organs such as stroke,coronary artery disease,heart failure and chronic kidney failure.However,among the existing treatments,hypertension remains poorly controlled worldwide,so,the therapeutic targets and the development of new antihypertensive drugs are still the top priority in the process of treating hypertension.

关 键 词：高血压 抗高血压药物 研究进展 

分 类 号：R972.4[医药卫生—药品]